Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Actuate Therapeutics, Inc. Common stock, Common Stock

ACTU

NMQ

$8.77

+$0.42

(5.03%)

Industry: Biotechnology Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$152.89M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

19.99K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$5.51 L

$10.16 H

$8.77

About Actuate Therapeutics, Inc. Common stock, Common Stock

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas. more

Industry: BiotechnologySector: Health Care

Returns

Time Frame	ACTU	Sector	S&P500
1-Week Return	1.04%	-0.09%	0.83%
1-Month Return	-	0.03%	5.98%
3-Month Return	7.02%	-6.26%	9.65%
6-Month Return	1.86%	1.16%	14.29%

Time Frame	ACTU	Sector	S&P500
1-Week Return	71.51%	-4.59%	53.88%
1-Month Return	0.00%	0.37%	102.72%
3-Month Return	31.67%	-23.06%	45.30%
6-Month Return	3.81%	2.37%	31.11%

Financials

	Dec '22	Dec '23
Total Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	20.21M	24.97M	[{"date":"2022-12-31","value":80.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	(20.21M)	(24.97M)	[{"date":"2022-12-31","value":-2020680700,"profit":false},{"date":"2023-12-31","value":-2497382900,"profit":false}]
Total Non-Operating Income/Expense	47.41K	229.21K	[{"date":"2022-12-31","value":20.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	(20.16M)	(24.74M)	[{"date":"2022-12-31","value":-2015940100,"profit":false},{"date":"2023-12-31","value":-2474462000,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(20.16M)	(24.74M)	[{"date":"2022-12-31","value":-2015940100,"profit":false},{"date":"2023-12-31","value":-2474462000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(20.16M)	(24.74M)	[{"date":"2022-12-31","value":-2015940100,"profit":false},{"date":"2023-12-31","value":-2474462000,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Dec '22	Dec '23
Total Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	23.59%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	-	23.59%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	383.50%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	-	22.74%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	22.74%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	22.74%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Sep '23	Dec '23	Mar '24	Jun '24	Sep '24	TREND
Total Revenue	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Cost of Revenue	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Gross Profit	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Operating Expenses	6.48M	7.62M	7.77M	5.44M	5.39M	[{"date":"2023-09-30","value":83.31,"profit":true},{"date":"2023-12-31","value":97.97,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-06-30","value":69.93,"profit":true},{"date":"2024-09-30","value":69.38,"profit":true}]
Operating Income	(6.48M)	(7.62M)	(7.77M)	(5.44M)	(5.39M)	[{"date":"2023-09-30","value":-647567300,"profit":false},{"date":"2023-12-31","value":-761518100,"profit":false},{"date":"2024-03-31","value":-777325400,"profit":false},{"date":"2024-06-30","value":-543544900,"profit":false},{"date":"2024-09-30","value":-539290300,"profit":false}]
Total Non-Operating Income/Expense	137.75K	3.03K	(522.80K)	(1.14M)	(578.06K)	[{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":2.2,"profit":true},{"date":"2024-03-31","value":-379.54,"profit":false},{"date":"2024-06-30","value":-825.25,"profit":false},{"date":"2024-09-30","value":-419.65,"profit":false}]
Pre-Tax Income	(6.34M)	(7.61M)	(8.30M)	(6.57M)	(5.97M)	[{"date":"2023-09-30","value":-633792500,"profit":false},{"date":"2023-12-31","value":-761215400,"profit":false},{"date":"2024-03-31","value":-829605900,"profit":false},{"date":"2024-06-30","value":-657221900,"profit":false},{"date":"2024-09-30","value":-597096100,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Income From Continuous Operations	(6.34M)	(7.61M)	(8.30M)	(6.57M)	(5.97M)	[{"date":"2023-09-30","value":-633792500,"profit":false},{"date":"2023-12-31","value":-761215400,"profit":false},{"date":"2024-03-31","value":-829605900,"profit":false},{"date":"2024-06-30","value":-657221900,"profit":false},{"date":"2024-09-30","value":-597096100,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Net Income	(6.34M)	(7.61M)	(8.30M)	(6.57M)	(5.97M)	[{"date":"2023-09-30","value":-633792500,"profit":false},{"date":"2023-12-31","value":-761215400,"profit":false},{"date":"2024-03-31","value":-829605900,"profit":false},{"date":"2024-06-30","value":-657221900,"profit":false},{"date":"2024-09-30","value":-597096100,"profit":false}]

EPS (Diluted)	-	-	-	(0.34)	(0.31)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":-33.65,"profit":false},{"date":"2024-09-30","value":-30.57,"profit":false}]

	Sep '23	Dec '23	Mar '24	Jun '24	Sep '24	TREND
Total Revenue	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Cost of Revenue	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Gross Profit	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Operating Expenses	-	17.60%	2.08%	(30.07%)	(0.78%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":11.8,"profit":true},{"date":"2024-06-30","value":-170.91,"profit":false},{"date":"2024-09-30","value":-4.45,"profit":false}]
Operating Income	-	17.60%	2.08%	(30.07%)	(0.78%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":11.8,"profit":true},{"date":"2024-06-30","value":-170.91,"profit":false},{"date":"2024-09-30","value":-4.45,"profit":false}]
Total Non-Operating Income/Expense	-	(97.80%)	(17371.39%)	117.44%	(49.15%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":-83.28,"profit":false},{"date":"2024-03-31","value":-14792.13,"profit":false},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":-41.85,"profit":false}]
Pre-Tax Income	-	20.10%	8.98%	(20.78%)	(9.15%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":44.69,"profit":true},{"date":"2024-06-30","value":-103.35,"profit":false},{"date":"2024-09-30","value":-45.5,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	20.10%	8.98%	(20.78%)	(9.15%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":44.69,"profit":true},{"date":"2024-06-30","value":-103.35,"profit":false},{"date":"2024-09-30","value":-45.5,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Net Income	-	20.10%	8.98%	(20.78%)	(9.15%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":44.69,"profit":true},{"date":"2024-06-30","value":-103.35,"profit":false},{"date":"2024-09-30","value":-45.5,"profit":false}]

EPS (Diluted)	-	-	-	-	(9.15%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":null,"profit":false}]

	Dec '22	Dec '23
Total Assets
Current Assets	20.48M	3.00M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.62,"profit":true}]
Non-current Assets	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Assets	20.48M	3.00M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.62,"profit":true}]

Total Liabilities
Current Liabilities	4.34M	6.92M	[{"date":"2022-12-31","value":62.78,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	91.44M	95.70M	[{"date":"2022-12-31","value":95.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	95.79M	102.62M	[{"date":"2022-12-31","value":93.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	(80.35M)	(105.09M)	[{"date":"2022-12-31","value":-8034990100,"profit":false},{"date":"2023-12-31","value":-10509452100,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	(75.31M)	(99.63M)	[{"date":"2022-12-31","value":-7530543200,"profit":false},{"date":"2023-12-31","value":-9962651300,"profit":false}]

Total Liabilities & Shareholders Equity	20.48M	3.00M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.62,"profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	-	(85.38%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Assets	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Assets	-	(85.38%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	59.28%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	-	4.66%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	7.13%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	30.80%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	32.30%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(85.38%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

	Dec '23	Mar '24	Jun '24	Sep '24
Total Assets
Current Assets	3.00M	2.19M	549.69K	14.26M	[{"date":"2023-12-31","value":21,"profit":true},{"date":"2024-03-31","value":15.34,"profit":true},{"date":"2024-06-30","value":3.85,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Non-current Assets	-	510.50K	1.18M	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":43.22,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Total Assets	3.00M	2.70M	1.73M	14.26M	[{"date":"2023-12-31","value":21,"profit":true},{"date":"2024-03-31","value":18.92,"profit":true},{"date":"2024-06-30","value":12.14,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	6.92M	14.73M	20.07M	8.50M	[{"date":"2023-12-31","value":34.48,"profit":true},{"date":"2024-03-31","value":73.4,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":42.33,"profit":true}]
Non-current Liabilities	95.70M	95.74M	95.91M	406.68K	[{"date":"2023-12-31","value":99.78,"profit":true},{"date":"2024-03-31","value":99.82,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":0.42,"profit":true}]
Total Liabilities	102.62M	110.47M	115.99M	8.90M	[{"date":"2023-12-31","value":88.48,"profit":true},{"date":"2024-03-31","value":95.25,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":7.68,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Retained Earnings	(105.09M)	(113.39M)	(119.96M)	(125.93M)	[{"date":"2023-12-31","value":-10509452100,"profit":false},{"date":"2024-03-31","value":-11339058000,"profit":false},{"date":"2024-06-30","value":-11996279900,"profit":false},{"date":"2024-09-30","value":-12593376000,"profit":false}]
Other Stockholders' Equity	-	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Total Shareholders' equity	(99.63M)	(107.77M)	(114.26M)	5.36M	[{"date":"2023-12-31","value":-1859.16,"profit":false},{"date":"2024-03-31","value":-2011.21,"profit":false},{"date":"2024-06-30","value":-2132.17,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	3.00M	2.70M	1.73M	14.26M	[{"date":"2023-12-31","value":21,"profit":true},{"date":"2024-03-31","value":18.92,"profit":true},{"date":"2024-06-30","value":12.14,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]

	Dec '23	Mar '24	Jun '24	Sep '24
Total Assets
Current Assets	-	(26.96%)	(74.88%)	2494.71%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-1.08,"profit":false},{"date":"2024-06-30","value":-3,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]
Non-current Assets	-	-	131.37%	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Total Assets	-	(9.91%)	(35.86%)	724.04%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-1.37,"profit":false},{"date":"2024-06-30","value":-4.95,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	112.90%	36.24%	(57.67%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-06-30","value":32.1,"profit":true},{"date":"2024-09-30","value":-51.08,"profit":false}]
Non-current Liabilities	-	0.04%	0.18%	(99.58%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":21.45,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":-54377.27,"profit":false}]
Total Liabilities	-	7.65%	4.99%	(92.32%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-06-30","value":65.25,"profit":true},{"date":"2024-09-30","value":-1206.8,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Retained Earnings	-	7.89%	5.80%	4.98%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-06-30","value":73.42,"profit":true},{"date":"2024-09-30","value":63.05,"profit":true}]
Other Stockholders' Equity	-	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Total Shareholders' equity	-	8.18%	6.01%	(104.69%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-06-30","value":73.54,"profit":true},{"date":"2024-09-30","value":-1280.08,"profit":false}]

Total Liabilities & Shareholders Equity	-	(9.91%)	(35.86%)	724.04%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":-1.37,"profit":false},{"date":"2024-06-30","value":-4.95,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	(17.79M)	(21.63M)	[{"date":"2022-12-31","value":-1779409300,"profit":false},{"date":"2023-12-31","value":-2162516700,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	19.26M	4.13M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":21.47,"profit":true}]

Net Change in Cash	1.46M	(17.49M)	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1196.78,"profit":false}]

Free Cash Flow
Free Cash Flow	(17.79M)	(21.63M)	[{"date":"2022-12-31","value":-1779409300,"profit":false},{"date":"2023-12-31","value":-2162516700,"profit":false}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	21.53%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(78.53%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Net Change in Cash	-	(1296.78%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	21.53%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Sep '23	Dec '23	Mar '24	Jun '24	Sep '24	TREND
Operating Activities
Net Operating Cash Flow	(5.64M)	(5.51M)	(5.25M)	(2.67M)	(9.15M)	[{"date":"2023-09-30","value":-563825100,"profit":false},{"date":"2023-12-31","value":-551184400,"profit":false},{"date":"2024-03-31","value":-524758200,"profit":false},{"date":"2024-06-30","value":-267363800,"profit":false},{"date":"2024-09-30","value":-914901300,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	4.36M	957.04K	22.32M	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":19.52,"profit":true},{"date":"2024-06-30","value":4.29,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Net Change in Cash	(5.64M)	(5.51M)	(890.35K)	(1.72M)	13.17M	[{"date":"2023-09-30","value":-42.81,"profit":false},{"date":"2023-12-31","value":-41.85,"profit":false},{"date":"2024-03-31","value":-6.76,"profit":false},{"date":"2024-06-30","value":-13.03,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(5.64M)	(5.51M)	(5.25M)	(2.67M)	(9.15M)	[{"date":"2023-09-30","value":-563825100,"profit":false},{"date":"2023-12-31","value":-551184400,"profit":false},{"date":"2024-03-31","value":-524758200,"profit":false},{"date":"2024-06-30","value":-267363800,"profit":false},{"date":"2024-09-30","value":-914901300,"profit":false}]

	Sep '23	Dec '23	Mar '24	Jun '24	Sep '24	TREND
Operating Activities
Net Operating Cash Flow	-	(2.24%)	(4.79%)	(49.05%)	242.19%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":-0.93,"profit":false},{"date":"2024-03-31","value":-1.98,"profit":false},{"date":"2024-06-30","value":-20.25,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	-	(78.04%)	2232.27%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":-3.5,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]

Net Change in Cash	-	(2.24%)	(83.85%)	92.80%	(867.32%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":-2.42,"profit":false},{"date":"2024-03-31","value":-90.35,"profit":false},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":-934.61,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(2.24%)	(4.79%)	(49.05%)	242.19%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":-0.93,"profit":false},{"date":"2024-03-31","value":-1.98,"profit":false},{"date":"2024-06-30","value":-20.25,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	ACTU
Current Ratio	1.68

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	ACTU
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	ACTU
Debt Ratio Lower is generally better. Negative is bad.	0.62
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.38

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	ACTU
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
Price/FCF	NM
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Actuate Therapeutics, Inc. Common stock share price today?

Actuate Therapeutics, Inc. Common stock (ACTU) share price today is $8.77

Can Indians buy Actuate Therapeutics, Inc. Common stock shares?

Yes, Indians can buy shares of Actuate Therapeutics, Inc. Common stock (ACTU) on Vested. To buy Actuate Therapeutics, Inc. Common stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ACTU stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Actuate Therapeutics, Inc. Common stock be purchased?

Yes, you can purchase fractional shares of Actuate Therapeutics, Inc. Common stock (ACTU) via the Vested app. You can start investing in Actuate Therapeutics, Inc. Common stock (ACTU) with a minimum investment of $1.

How to invest in Actuate Therapeutics, Inc. Common stock shares from India?

You can invest in shares of Actuate Therapeutics, Inc. Common stock (ACTU) via Vested in three simple steps:

Click on Sign Up or Invest in ACTU stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Actuate Therapeutics, Inc. Common stock shares

What is Actuate Therapeutics, Inc. Common stock 52-week high and low stock price?

The 52-week high price of Actuate Therapeutics, Inc. Common stock (ACTU) is $10.16. The 52-week low price of Actuate Therapeutics, Inc. Common stock (ACTU) is $5.51.

What is Actuate Therapeutics, Inc. Common stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Actuate Therapeutics, Inc. Common stock (ACTU) is

What is Actuate Therapeutics, Inc. Common stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Actuate Therapeutics, Inc. Common stock (ACTU) is 0.00

What is Actuate Therapeutics, Inc. Common stock dividend yield?

The dividend yield of Actuate Therapeutics, Inc. Common stock (ACTU) is 0.00%

What is the Market Cap of Actuate Therapeutics, Inc. Common stock?

The market capitalization of Actuate Therapeutics, Inc. Common stock (ACTU) is $152.89M

What is Actuate Therapeutics, Inc. Common stock’s stock symbol?

The stock symbol (or ticker) of Actuate Therapeutics, Inc. Common stock is ACTU